The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy-Reference-Cited by-同舟云学术

The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy

Published:2021-03-31 Issue:7 Volume:26 Page:1293-1303
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Takeda Tsuyoshi,Sasaki Takashi^ORCID,Suzumori Chisaki,Mie Takafumi,Furukawa Takaaki,Yamada Yuto,Kasuga Akiyoshi,Matsuyama Masato,Ozaka Masato,Sasahira Naoki

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-021-01912-0.pdf

Reference30 articles.

1. Siegel RL, Miller KD, Jemal A (2020) Cancer statistics. CA Cancer J Clin 70(1):7–30

2. Suker M, Beumer BR, Sadot E et al (2016) FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol 17(6):801–810

3. Conroy T, Desseigne F, Ychou M et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364(19):1817–1825

4. Von Hoff DD, Ervin T, Arena FP et al (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369(18):1691–1703

5. Li X, Huang DB, Zhang Q et al (2020) The efficacy and toxicity of chemotherapy in the elderly with advanced pancreatic cancer. Pancreatology 20(1):95–100

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluación del papel de la sarcopenia y de los parámetros de la PET/TC con [18F]FDG en el pronóstico del adenocarcinoma ductal de páncreas;Revista Española de Medicina Nuclear e Imagen Molecular;2024-09

2. Evaluation of comprehensive geriatric assessment for older adults with pancreaticobiliary cancers: A retrospective observational study;Journal of Geriatric Oncology;2024-09

3. Evaluating the role of sarcopenia and [18F]FDG PET/CT parameters in prognosis of pancreatic ductal adenocarcinoma;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2024-08

4. Impact of baseline body composition on prognostic outcomes in urological malignancies treated with immunotherapy: a pooled analysis of 10 retrospective studies;BMC Cancer;2024-07-11

5. Pancreatic cancer and sarcopenia: a narrative review of the current status;International Journal of Clinical Oncology;2024-07-02